Tumor Interstitial Fluid Pressure—A Link between Tumor Hypoxia, Microvascular Density, and Lymph Node Metastasis  by Rofstad, Einar K. et al.
www.neoplasia.com
Volume 16 Number 7 July 2014 pp. 586–594 586
Abbreviati
density; LY
density; V
Address all
Institute fo
Oslo, Norw
Financial s
Eastern No
conflicts o
Received 1
© 2014 N
under the
1476-5586
http://dx.dTumor Interstitial Fluid Pressure—A
Link between Tumor Hypoxia,
Microvascular Density,
and Lymph Node Metastasisons: HF, hypoxic fraction; IFP, interstitial fluid pressure; LVD, lymph vessel
VE-1, lymphatic endothelial hyaluronan receptor-1; MVD, microvascular
EGF, vascular endothelial growth factor
correspondence to: Einar K. Rofstad PhD, Department of Radiation Biology,
r Cancer Research, Norwegian RadiumHospital, Box 4953 Nydalen, N-0424
ay. E-mail: einar.k.rofstad@rr-research.no
upport was received from the Norwegian Cancer Society and the South-
rway Regional Health Authority. Conflicts of interest: The authors have no
f interest to disclose.
2 June 2014; Revised 8 July 2014; Accepted 11 July 2014
eoplasia Press, Inc. Published by Elsevier Inc. This is an open access article
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
/14
oi.org/10.1016/j.neo.2014.07.003Einar K. Rofstad , Kanthi Galappathi and
Berit S. Mathiesen
Department of Radiation Biology, Institute for Cancer Research,
Oslo University Hospital, Oslo, NorwayAbstract
High microvascular density (MVD) in the primary tumor has been shown to be associated with increased incidence
of lymph node metastases and poor clinical outcome. Other investigations have revealed that a large fraction of
hypoxic tissue in the primary tumor is associated with metastatic disease and impaired survival. These data are
apparently incompatible because tumor hypoxia is primarily a consequence of poor oxygen supply caused by an
inadequate vasculature with increased intervessel distances. Here, we provide an explanation of these
observations. Human melanoma xenografts were used as preclinical cancer models. Tumors that metastasized
to lymph nodes showed higher interstitial fluid pressure (IFP) than those that did not metastasize, and compared
with tumors with low IFP, tumors with high IFP showed large hypoxic fractions centrally, high MVD in the
periphery, high peritumoral density of lymphatics, and elevated expression of vascular endothelial growth factor A
(VEGF-A) and VEGF-C. Significant correlations were found between peripheral MVD and central hypoxia, and
lymph node metastasis was associated with high values of both parameters. These findings suggest that the
outcome of cancer may be associated with both high MVD and extensive hypoxia in the primary tumor. We
propose that proangiogenic factors are upregulated in the tumor center and that the outward interstitial fluid flow
caused by the elevated IFP transports these factors to the tumor surface where they evoke hemangiogenesis and
lymphangiogenesis, and consequently, that the IFP serves as a link between tumor hypoxia, peripheral tumor
hemangiogenesis, peritumoral lymphangiogenesis, and lymph node metastasis.
Neoplasia (2014) 16, 586–594Introduction
Angiogenesis plays an important role in the progression of malignant
diseases [1], and there is substantial evidence that the prognosisof patients with cancer is associated with the angiogenic potential
of the primary tumor [2–4]. Clinical studies involving a wide range of
cancer types have demonstrated significant correlations between
disease-free or overall survival rate and tumor microvascular density
(MVD) [4]. Furthermore, tumor MVD has been shown to be
significantly higher in patients with metastases than in metastasis-free
patients in many cancer diseases, including breast carcinoma [5],
prostate carcinoma [6], squamous cell carcinoma of the head and
neck [7], lung carcinoma [8], bladder carcinoma [9], ovarian
carcinoma [10], and malignant melanoma [11–13]. Interestingly,
most of these cancer types metastasize to regional lymph nodes
through functional lymphatics adjacent to the primary tumor,
whereas MVD was scored by determining the density of blood
vessels in vascular hot spots within the primary tumor [4]. Vascular
hot spots can occur anywhere in tumors but are seen primarily
in the invasive front [14], consistent with the observation that MVD
increases gradually from the center to the periphery of tumors [15].
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morphologic and architectural abnormalities [16–18]. These abnor-
malities result in elevated geometric and viscous resistance to blood
flow, increased transvascular fluid flow, inadequate perfusion, and
heterogeneous supply of oxygen and nutrients [16,17]. Therefore,
many macroscopic tumors show a physiological microenvironment
characterized by nutrient deprivation, high interstitial fluid pressure
(IFP), and hypoxia [17,18]. There is significant evidence that these
abnormalities promote metastatic dissemination and tumor growth at
regional and distant sites [18,19]. Several preclinical studies have
suggested that tumors with high fractions of hypoxic cells
metastasize more frequently than genetically equivalent tumors
with low hypoxic fractions (HFs) [20–24], and highly elevated IFP
has been shown to be associated with increased incidence of
pulmonary and lymph node metastases in human melanoma and
cervical carcinoma xenografts [25,26]. Clinical investigations have
revealed that extensive hypoxia in the primary tumor is associated with
malignant progression, development of metastatic disease, and poor
disease-free and overall survival rates in a large number of cancer types
[27–30]. Studies of patients with locally advanced cervical carcinoma
have suggested that high IFP in the primary tumor is linked to high
incidence of distantmetastases, pelvic recurrence after radiation therapy,
and impaired survival [31,32].
Large HFs in tumors and hypoxia-induced resistance to
radiation therapy have been shown to be associated with low
tumor MVD in several cancer types, including cervical carcinoma
[33] and carcinoma of the head and neck [34], consistent with the
generally accepted view that tumor hypoxia is primarily a
consequence of poor oxygen supply caused by elevated resistance
to blood flow and increased intervessel distances [17,18]. The
significant number of studies suggesting that lymph node
metastasis and poor survival rates are associated with high tumor
MVD is apparently inconsistent with those suggesting that
metastasis and poor outcome are a consequence of tumor hypoxia.
It has been proposed, however, that high MVD may result from
hypoxia-induced angiogenesis mediated by proangiogenic factors
that are upregulated by hypoxia and, hence, that the two sets of
apparently inconsistent observations are not mutually exclusive.
Although hypoxia-induced angiogenesis may be important, this is
not a satisfactory explanation because hypoxic tissue usually exists in the
central regions of tumors [17], whereas high MVD and microvascular
hot spots are seen primarily in the tumor periphery [14].
In the work reported in this communication, possible relationships
between tumor hypoxia, intratumoral MVD, and lymph node
metastasis were studied by using human melanoma xenografts as
experimental models of human cancer. The main purpose of the study
was to provide plausible explanations for 1) the observations that cancer
metastasis may be associated with both the fraction of hypoxic
tissue and the MVD of the primary tumor and 2) the observations
that the density of blood vessels within primary tumors may be
associated with lymphogenous metastatic spread. We hypothesized
that the elevated IFP and the associated interstitial fluid flow of
tumors may serve as a link between tumor hypoxia, MVD, and
lymph node metastasis. This hypothesis was investigated by
measuring the central IFP, the central fraction of hypoxic tissue,
and the peripheral MVD of metastatic and non-metastatic R-18
and T-22 tumors and relating the observations to established
correlations between IFP, rate of interstitial fluid flow, and lymph
node metastasis.Materials and Methods
Mice
Adult (8-10 weeks of age) female BALB/c nu/nu mice, bred and
maintained under specific pathogen-free conditions, were used as
host animals for tumors. The animal experiments were approved by
the Institutional Committee on Research Animal Care and were done
according to the US Public Health Service Policy on Humane Care
and Use of Laboratory Animals.
Tumors
The R-18 and T-22 human melanoma cell lines were established in
our laboratory as described earlier [35]. The cells used in the present
experiments were obtained from our frozen stock and were
maintained in monolayer culture in Roswell Park Memorial Institute
1640 (25 mmol/l Hepes and L-glutamine) medium supplemented with
13% bovine calf serum, 250 mg/l penicillin, and 50mg/l streptomycin.
Xenografted tumors were initiated by inoculating aliquots of ~3.5 × 105
R-18 cells or ~1.0 × 106 T-22 cells intradermally into the left mouse
flank. The tumors were included in experiments when they had grown
to a volume of ~400 mm3. R-18 and T-22 tumors of this size do not
show significant regions with necrotic tissue.
Hypoxia, Density of Blood and Lymph Vessels, and Expression
of Vascular Endothelial Growth Factor A and Vascular
Endothelial Growth Factor C
Hypoxic tissue, blood vessels, lymphatics, vascular endothelial growth
factor A (VEGF-A), and VEGF-C were detected by immunohisto-
chemistry [36]. Pimonidazole [1-[(2-hydroxy-3-piperidinyl)-propyl]-2-
nitroimidazole], injected as described previously [23], was used as a
marker of tumor hypoxia, and CD31 and lymphatic endothelial
hyaluronan receptor-1 (LYVE-1) were used as markers of blood and
lymph vessel endothelial cells, respectively. An anti-pimonidazole rabbit
polyclonal antibody (Professor Raleigh, University of North Carolina,
Chapel Hill, NC), an anti-mouse CD31 rat monoclonal antibody
(Research Diagnostics, Flanders, NJ), an anti-mouse LYVE-1 rabbit
polyclonal antibody (Abcam, Cambridge, United Kingdom), an anti-
human VEGF-A rabbit polyclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA), or an anti-human VEGF-C goat polyclonal antibody
(Abcam) was used as primary antibody.Quantitative studies were carried
out on preparations cut sagittally through the central regions of tumors
and the surrounding skin, and four sections were analyzed for each
tumor. Microvessels were defined and scored manually as described by
Weidner [14]. Blood vessel density in the invasive front (peripheral
MVD) was determined by counting vessels located within a 1-mm-thick
band in the tumor periphery (Figure 1, A and B). Peritumoral density of
lymphatics [peritumoral lymph vessel density (LVD)] was assessed by
counting vessels in the surrounding skin located within a distance of 0.5
mm from the tumor surface. Fraction of hypoxic tissue was assessed by
image analysis and was defined as the area fraction of the tissue showing
positive pimonidazole staining. HF in the tumor center (central HFPim)
was measured by analyzing the tissue located inside the invasive front,
that is, further in from the tumor surface than 1mm (Figure 1,A andB).
VEGF-A Concentration
VEGF-A concentrations were measured in tumors frozen in liquid
nitrogen immediately after resection [37]. The frozen tissue was
pulverized and lysed in radioimmunoprecipitation assay buffer. The
samples were centrifuged and the supernatants were stored at −80°C
until analysis. Total protein concentrations were determined by using
Figure 1. (A and B) Immunohistochemical preparations of two T-22 tumors stained for the hypoxia marker pimonidazole, one with
a high HF (A) and the other with a low HF (B). The red lines indicate the border between the peripheral and central tumor regions. (C and D)
Immunohistochemical preparations of the peripheral (C) and central (D) regions of the tumor in (A) stained for CD31.
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ELISA kit (Quantikine; R&D Systems, Abingdon, United Kingdom)
was used according to the manufacturer’s protocol to measure VEGF-
A concentrations, and the resulting concentrations were normalized
by the total protein concentration.
Interstitial Fluid Pressure
IFP was measured in the center of tumors by using the wick-in-needle
method [37]. Before measurements, the host mice were anesthetized
with 0.63 mg/kg fentanyl citrate (Janssen Pharmaceutica, Beerse,
Belgium), 20 mg/kg fluanisone (Janssen Pharmaceutica), and 10 mg/kg
midazolam (Hoffmann-La Roche, Basel, Switzerland).
Lymph Node Metastasis
Spontaneous metastasis was studied as described elsewhere [22].
The mice were killed immediately after the IFP measurement, and
after the primary tumor was resected, they were examined for external
lymph node metastases in the inguinal, axillary, interscapular, and
submandibular regions and internal lymph node metastases in the
abdomen and mediastinum. The presence of metastatic growth in
enlarged lymph nodes was confirmed by histologic examination [23].
Statistical Analysis
Curves were fitted to data by regression analysis. The Pearson
product moment correlation test was used to search for correlations
between parameters. Statistical comparisons of data were carried out
with the Student's t test when the data complied with the conditions of
normality and equal variance. Under other conditions, comparisons
were carried out by nonparametric analysis using the Mann-Whitneyrank-sum test. Probability values of P b .05, determined from two-sided
tests, were considered significant. The statistical analysis was performed
by using the SigmaStat statistical software (SPSS Science, Chicago, IL).
Results
Fraction of hypoxic tissue differed substantially among individual R-18
and T-22 tumors, as illustrated by immunohistochemical preparations of
two distinctly different T-22 tumors (Figure 1, A and B). The red line in
these images indicates the border between the central and peripheral
tumor regions. Positive pimonidazole staining was seen almost
exclusively in the central region, both in R-18 and T-22 tumors.
Moreover, immunohistochemical preparations stained for CD31
revealed that the tumors of both lines had higherMVD in the peripheral
region than in the central region, as illustrated by using the T-22 tumor
depicted in Figure 1A as an example (Figure 1, C and D).
IFP, central HFPim, and peripheral MVD were measured in 20 R-18
tumors (Figure 2A) and 20 T-22 tumors (Figure 2B). In tumors with IFP
below ~20 mmHg, central HFPim and peripheral MVD did not vary with
increasing IFP in any of the lines (P N .05). In tumors with IFP above ~20
mmHg, however, both lines showed a positive correlation between central
HFPim and IFP [P = .024, R
2 = 0.49 (R-18); P = .012, R2 = 0.56 (T-22)]
and between peripheral MVD and IFP [P = .0027,R2 = 0.69 (R-18); P =
.011, R2 = 0.57 (T-22)]. Moreover, regardless of IFP, there was a
significant correlation between peripheralMVD and central HFPim in both
R-18 (P b .00001, R2 = 0.70) and T-22 (P b .00001, R2 = 0.73) tumors.
Nine of the 20 mice with R-18 tumors and 7 of the 20 mice with
T-22 tumors developed lymph node metastases, whereas the other
mice were metastasis-negative. The metastatic tumors had signifi-
cantly higher IFP, central HFPim, and peripheral MVD than the non-
Figure 2. Plots of central HFPim versus IFP, peripheral MVD versus IFP, and peripheral MVD versus central HFPim for 20 R-18 (A) and 20 T-22
(B) tumors. The points represent single tumors.
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.00055 (central HFPim), P = .0016 (peripheral MVD); Figure 3A]
and the T-22 line [P = .00097 (IFP), P = .0020 (central HFPim), P =
.00042 (peripheral MVD); Figure 3B].
VEGF-A expression, VEGF-C expression, and peritumoral
LVD differed between tumors with high IFP (IFP N 20 mmHg) and
tumors with low IFP (IFP b 20mmHg) in both lines. This is illustrated
qualitatively in Figure 4, which shows immunohistochemical prepara-
tions of two R-18 tumors with highly different IFP stained for VEGF-A
(Figure 4A), VEGF-C (Figure 4B), and lymphatics (Figure 4, C andD).
The central tumor regions showed relatively homogeneous staining for
both VEGF-A and VEGF-C independent of tumor IFP, and the
vasculature in the tumor periphery was highlighted by strong VEGF-A
staining. The staining intensity centrally was substantially stronger in the
tumors with high IFP than in the tumors with low IFP, both for VEGF-
A (Figure 4A) and VEGF-C (Figure 4B). Peritumoral lymphatics stained
positively for LYVE-1 and were easily identifiable, whereas intratumoral
lymphatics could not be detected by LYVE-1 immunohistochemistry(Figure 4C). The tumors with high IFP generally showed higher
peritumoral LVD than the tumors with low IFP (Figure 4D).
The concentration of VEGF-A and peritumoral LVDweremeasured
in eight R-18 and eight T-22 tumors with IFP b 20mmHg and eight R-
18 and eight T-22 tumors with IFP N 20mmHg. The tumors with high
IFP had significantly higher VEGF-A concentration and peritumoral
LVD than the tumors with low IFP, both in the R-18 line [P = .00014
(VEGF-A concentration), P = .0039 (peritumoral LVD); Figure 5A]
and the T-22 line [P = .0024 (VEGF-A concentration), P = .00081
(peritumoral LVD); Figure 5B].
Discussion
High angiogenic activity and a high fraction of hypoxic tissue in the
primary tumor have been shown to be associated with high incidence
of lymph node metastases, poor outcome of treatment, and decreased
survival rates in several histologic types of cancer [2–15,27–30]. In
the present communication, we provide experimental evidence that
lymphogenous metastasis can be associated with both the HF and the
Figure 3. IFP, central HFPim, and peripheral MVD of nonmetastatic and metastatic R-18 (A) and nonmetastatic and metastatic T-22
(B) tumors. The points represent single tumors. The horizontal lines indicate mean values.
590 Tumor interstitial fluid pressure Rofstad et al. Neoplasia Vol. 16, No. 7, 2014MVD of tumors and suggest a possible mechanism for these apparently
incongruous observations.
Human melanoma xenografts growing intradermally in the flank
of athymic mice were used as preclinical models of human cancer.
Dynamic contrast-enhanced magnetic resonance imaging studies and
histologic examinations have revealed that tumors transplanted to this
orthotopic site are not isotropic [38]. Blood perfusion and MVD are
low in the tumor center and increase toward the periphery in the
cranial, dorsal, caudal, and ventral directions, but not in the lateral
and medial directions, possibly because any radial gradients in the
lateral and medial directions are lost during tumor growth owing to
vessel deteriorations caused by mechanical pressure generated by the
expanding tumor mass. The histologic sections studied in this
investigation were cut in the sagittal plane because vascular gradients
appear in all directions in this plane.
Two tumor lines were included in the study, and it was revealed
that MVD was higher in the tumor periphery than in the tumor
center and that the central regions, in contrast to the peripheral
regions, showed significant pimonidazole staining. Moreover,
peripheral MVD was positively correlated with central HFPim, and
the metastatic tumors had higher central HFPim and higher peripheral
MVD than the nonmetastatic tumors. Interestingly, the tumors with
high IFP (IFP N 20 mmHg) showed higher central HFPim, higherperipheral MVD, higher peritumoral LVD, higher expression of
VEGF-A and VEGF-C, and metastasized more frequently to lymph
nodes than the tumors with low IFP (IFP b 20 mmHg).
Based on these data, we suggest that tumor IFP forms a link
between tumor angiogenesis, tumor hypoxia, and lymph node
metastasis and that the following mechanism was responsible for our
observations. Abnormal angiogenesis led to the development of
microvascular networks with severe architectural abnormalities, and
these abnormalities resulted in a physiological microenvironment
centrally in the tumors characterized by elevated IFP and regions with
hypoxic tissue. Tumor hypoxia and interstitial hypertension caused
up-regulation of VEGF-A, VEGF-C, and possibly also other
stimulators of hemangiogenesis and lymphangiogenesis. Because
of the elevated IFP in the central tumor regions, interstitial fluid
flowed from the center toward the periphery and transported these
proangiogenic factors to the tumor surface where they promoted
tumor hemangiogenesis and peritumoral lymphangiogenesis, and
subsequently, lymph node metastasis increased because of increased
VEGF-C–mediated lymphangiogenesis in the peritumoral tissue.
The different steps of the suggested mechanism are in accordance
with the current literature. Thus, there is substantial evidence from
preclinical studies that tumor hypoxia and interstitial hypertension
are caused primarily by microvascular abnormalities [17,18,39] and
Figure 4. Immunohistochemical preparations of two R-18 tumors stained for VEGF-A (A), VEGF-C (B), and LYVE-1 (C) and of the
peritumoral skin of the tumors stained for LYVE-1 (C and D). Peritumoral lymphatics stained positively for LYVE-1 (C and D), whereas
intratumoral lymphatics could not be detected (C). The images to the left refer to a tumor with a low IFP of 7 mmHg and those to the right
to a tumor with a high IFP of 31 mmHg.
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of VEGF-A, VEGF-C, and other proangiogenic factors [18,40,41].
Theoretical as well as experimental studies have revealed that IFP is
homogeneously elevated throughout the central regions of tumors
and drops steeply to normal tissue values at the tumor periphery,resulting in an outward flow of interstitial fluid at the tumor surface
[42–44]. It has been shown that the velocity of the peritumoral
interstitial fluid flow correlates positively with IFP and the incidence
of lymph node metastases in melanoma and cervical carcinoma
xenografts [26]. Furthermore, high peritumoral interstitial fluid flow
Figure 5. VEGF-A concentration and peritumoral LVD of R-18 (A) and T-22 (B) tumors with low (IFP b 20 mmHg) and high (IFP N 20 mmHg)
IFP. The points represent single tumors. The horizontal lines indicate mean values.
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metastasis in patients diagnosed with locally advanced carcinoma of
the uterine cervix [26].
In addition to microvascular abnormalities, impaired lymphatic
drainage has been identified as a key contributor to the development
of interstitial hypertension in tumors [45,46], and consequently,
the present observation of an association between high IFP and
high peritumoral LVD is counterintuitive. Tumor-induced lym-
phangiogenesis may produce lymphatics with severe morphologic
and functional abnormalities, analogous to the observation that
tumor hemangiogenesis may result in the development of abnormal
blood vessels. Thus, it has been observed that some tumors show
overexpression of prolymphangiogenic factors and that these factors
may evoke hyperplasia of peritumoral lymphatics and produce
immature lymphatics with reduced draining capacity [47,48].
Most likely, the peritumoral lymphangiogenesis induced by VEGF-C
in R-18 and T-22 tumors with high IFP was not sufficient to have any
impact on the IFP of the tumors, either because the magnitude of the
increase in peritumoral LVD was too small or because the functional
ability of the lymphatics was subnormal.
Recently, Hofmann et al. [49] studied effects of lymphangiogenesis
on tumor IFP by injecting high doses of VEGF-C in the peritumoraltissue of epidermoid vulva carcinoma xenografts and showed that this
VEGF-C treatment resulted in strong intratumoral lymphangiogen-
esis, distinct lymphatics within the tumor tissue, and decreased IFP.
Our finding of an association between high IFP and high peritumoral LVD
is apparently contradictory to the observation of Hofmann et al. [49].
However, there is a significant difference between these two studies.
Intratumoral lymphatics could not be seen in any of the R-18 and T-22
tumors, regardless of IFP, whereas the VEGF-C treatment used by
Hofmann et al. [49] evoked strong intratumoral lymphangiogenesis.
It is possible that a significant VEGF-C–induced decrease in the IFP
of tumors may require induction of functional lymphatic within the
malignant tumor tissue.
Most previous studies have failed to demonstrate a correlation
between the IFP of tumors and tumor hypoxia, both in patients with
cervical cancer [31] and in experimental tumor models [50–52],
whereas in this study, a positive correlation was found between central
HFPim and IFP in tumors with IFP N 20 mmHg. Different methods
were used to measure hypoxia, and in the previous studies, fraction of
hypoxic tissue referred to the total tumor volume. Moreover, the
detection of any correlation may have been complicated by a large
proportion of tumors with relatively low IFP values. Interestingly,
in a previous investigation, we measured IFP values ranging from 2 to
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correlation was found between IFP and fraction of acutely
hypoxic cells but not between IFP and fraction of chronically
hypoxic cells [53].
In contrast to R-18 and T-22 tumors, tumors of the A-07
line rarely show IFP values above 20 mmHg [25,53], and A-07
tumors generally develop lymph node metastases less frequently than
R-18 and T-22 tumors [22,23,25]. For example, in a previous study
of A-07 tumors, lymph node metastases were detected in 11 of 50
mice (22%) [25], whereas the incidence of lymph node metastases
was 45% for the R-18 tumors and 35% for the T-22 tumors in the
present study. However, A-07 tumors develop pulmonary metastases
frequently [24,25,36], whereas hematogenous spread to the lungs has
not been observed for R-18 and T-22 tumors [22,36]. Furthermore,
A-07 tumors have a shorter volume doubling time and a substantially
higher MVD than R-18 and T-22 tumors [35]. Taken together,
our observations suggest that A-07 tumors are more aggressive than
R-18 and T-22 tumors [35], most likely because the synthesis and
secretion of the proangiogenic factors VEGF-A and interleukin-8 are
manyfold higher in A-07 tumors than in other melanoma xenografts
we have studied [36].
The mechanism we suggest here implies that lymph node metastasis
was primarily a result of microenvironment-induced activation of
peritumoral lymphatics mediated by VEGF-C, but other metastasis-
promoting factors transported by the interstitial fluid may have been
involved as well.However, there was probably not any causal relationship
between lymph node metastasis and peripheral MVD. An association
between these parameters was probably observed because the outward
flow of interstitial fluid brought VEGF-A and other proangiogenic
factors to the tumor surface, but it is not likely that the increased
peripheral vascularity played a significant role as an escape route for cells
giving rise to lymph node metastases.
In conclusion, this preclinical study shows that lymph node
metastasis can be associated with the fraction of hypoxic tissue in the
central regions of tumors as well as the MVD in the tumor periphery,
probably because interstitial hypertension and the associated interstitial
fluid flow act as a link between tumor hypoxia, peripheral tumor
angiogenesis, peritumoral lymphangiogenesis, and the development of
lymph node metastases. Consequently, the apparently incongruous
observations that the clinical outcome of cancer is associatedwith tumor
MVD and with tumor hypoxia are not mutually exclusive.
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